AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions that also yielded positive results for a late-stage rare disease drug on Monday.

EsoBiotec, a small privately held firm, develops in-vivo CAR-T cell therapies that empower the immune system to attack cancers, and could offer many more patients access to cell therapy treatments, provided in minutes rather than weeks.

The deal marks the latest acquisition by AstraZeneca, which is Britain’s biggest listed company valued at £184bn, as the pharmaceutical group continues to expand its global operations. Its share price fell by 1.2% on Monday afternoon.

Read Full Article Here
 
Astra Zeneca by is licensed under flickr

Follow us

Read our latest news on any of these social networks!

Get latest news delivered daily!

We will send you breaking news right to your inbox


Have a tip? Let us know!

Recent Articles

...
Supreme Court allows Mississippi to require age verification on social media like Facebook and X

The Supreme Court has refused for now to block enforcement of a Mississippi law aimed at regulating the use of social media by children

...
Florida governor says state will open ‘deportation depot’ immigration jail

Ron DeSantis announced move as judge to decide whether to close ‘Alligator Alcatraz’ facility in Everglades

...
AI used to design antibiotics that can combat drug-resistant superbugs gonorrhoea and MRSA

Antibiotics are used to kill bacteria, but some infections have become resistant to drugs. It is estimated drug-resistant bacterial infections cause nearly five million deaths per year worldwide.

...
Melania Trump makes bombshell $1 billion threat against Hunter Biden after 'inflammatory' Epstein comments

First lady Melania Trump is threatening to sue Hunter Biden for $1 billion after he made the false claim that she was introduced to President Donald Trump by serial pedophile Jeffrey Epstein.